LENALIDOMIDE for Plasma cell myeloma in remission: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 4,678 adverse event reports in the FDA FAERS database where LENALIDOMIDE was used for Plasma cell myeloma in remission.

Most Reported Side Effects for LENALIDOMIDE

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	27,576	7.9%	545	4,623
Fatigue	22,956	6.6%	444	2,907
Death	19,213	5.5%	19,190	1,415
Off label use	17,017	4.9%	1,252	3,116
Rash	15,794	4.5%	315	1,830
Pneumonia	14,807	4.2%	1,646	11,418
Plasma cell myeloma	14,191	4.1%	5,427	2,477
Neuropathy peripheral	10,215	2.9%	210	988
White blood cell count decreased	9,996	2.9%	176	1,895
Constipation	9,635	2.8%	183	1,395
Nausea	9,206	2.6%	250	1,848
Asthenia	8,192	2.3%	424	2,679
Product dose omission issue	8,145	2.3%	24	691
Platelet count decreased	7,491	2.1%	397	1,855
Neutropenia	6,909	2.0%	670	1,451